Identifying the best machine learning algorithms for brain tumor segmentation, progression assessment, and overall survival prediction in the BRATS challenge S Bakas, M Reyes, A Jakab, S Bauer, M Rempfler, A Crimi, RT Shinohara, ... arXiv preprint arXiv:1811.02629, 2018 | 2061 | 2018 |
Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma D Sturm, H Witt, V Hovestadt, DA Khuong-Quang, DTW Jones, ... Cancer cell 22 (4), 425-437, 2012 | 2020 | 2012 |
The liver tumor segmentation benchmark (lits) P Bilic, P Christ, HB Li, E Vorontsov, A Ben-Cohen, G Kaissis, A Szeskin, ... Medical Image Analysis 84, 102680, 2023 | 1262 | 2023 |
Brain tumour cells interconnect to a functional and resistant network M Osswald, E Jung, F Sahm, G Solecki, V Venkataramani, J Blaes, S Weil, ... Nature 528 (7580), 93-98, 2015 | 1016 | 2015 |
A vaccine targeting mutant IDH1 induces antitumour immunity T Schumacher, L Bunse, S Pusch, F Sahm, B Wiestler, J Quandt, O Menn, ... Nature 512 (7514), 324-327, 2014 | 796 | 2014 |
The rsna-asnr-miccai brats 2021 benchmark on brain tumor segmentation and radiogenomic classification U Baid, S Ghodasara, S Mohan, M Bilello, E Calabrese, E Colak, ... arXiv preprint arXiv:2107.02314, 2021 | 753 | 2021 |
Deep autoencoding models for unsupervised anomaly segmentation in brain MR images C Baur, B Wiestler, S Albarqouni, N Navab Brainlesion: Glioma, Multiple Sclerosis, Stroke and Traumatic Brain Injuries …, 2019 | 609 | 2019 |
ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an “integrated” diagnostic approach for … DE Reuss, F Sahm, D Schrimpf, B Wiestler, D Capper, C Koelsche, ... Acta neuropathologica 129, 133-146, 2015 | 514 | 2015 |
Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate L Bunse, S Pusch, T Bunse, F Sahm, K Sanghvi, M Friedrich, D Alansary, ... Nature medicine 24 (8), 1192-1203, 2018 | 469 | 2018 |
ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis B Wiestler, D Capper, T Holland-Letz, A Korshunov, A Von Deimling, ... Acta neuropathologica 126, 443-451, 2013 | 423 | 2013 |
Yes and PI3K bind CD95 to signal invasion of glioblastoma S Kleber, I Sancho-Martinez, B Wiestler, A Beisel, C Gieffers, O Hill, ... Cancer cell 13 (3), 235-248, 2008 | 370 | 2008 |
Autoencoders for unsupervised anomaly segmentation in brain MR images: a comparative study C Baur, S Denner, B Wiestler, N Navab, S Albarqouni Medical Image Analysis 69, 101952, 2021 | 362 | 2021 |
IDH mutation status is associated with a distinct hypoxia/angiogenesis transcriptome signature which is non-invasively predictable with rCBV imaging in human … P Kickingereder, F Sahm, A Radbruch, W Wick, S Heiland, A Deimling, ... Scientific reports 5 (1), 16238, 2015 | 341 | 2015 |
Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system C Koelsche, F Sahm, D Capper, D Reuss, D Sturm, DTW Jones, M Kool, ... Acta neuropathologica 126, 907-915, 2013 | 337 | 2013 |
Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation W Wick, C Meisner, B Hentschel, M Platten, A Schilling, B Wiestler, ... Neurology 81 (17), 1515-1522, 2013 | 280 | 2013 |
VerSe: A vertebrae labelling and segmentation benchmark for multi-detector CT images A Sekuboyina, ME Husseini, A Bayat, M Löffler, H Liebl, H Li, G Tetteh, ... Medical Image Analysis, 102166, 2021 | 260 | 2021 |
Relaxation-compensated CEST-MRI of the human brain at 7 T: unbiased insight into NOE and amide signal changes in human glioblastoma M Zaiss, J Windschuh, D Paech, JE Meissner, S Burth, B Schmitt, ... Neuroimage 112, 180-188, 2015 | 249 | 2015 |
Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets F Sahm, D Schrimpf, DTW Jones, J Meyer, A Kratz, D Reuss, D Capper, ... Acta neuropathologica 131, 903-910, 2016 | 247 | 2016 |
Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma B Wiestler, D Capper, M Sill, DTW Jones, V Hovestadt, D Sturm, ... Acta neuropathologica 128, 561-571, 2014 | 240 | 2014 |
Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide W Wick, P Roth, C Hartmann, P Hau, M Nakamura, F Stockhammer, ... Neuro-oncology 18 (11), 1529-1537, 2016 | 223 | 2016 |